PLSI Stock Overview
Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Phoenix Life Sciences International Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0001 |
52 Week High | US$0.82 |
52 Week Low | US$0.0001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -99.97% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
PLSI | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | -2.2% | -3.7% |
1Y | n/a | 11.6% | 20.5% |
Return vs Industry: Insufficient data to determine how PLSI performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how PLSI performed against the US Market.
Price Volatility
PLSI volatility | |
---|---|
PLSI Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PLSI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PLSI's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | n/a | Willis Victory | www.phoenixlife.co |
Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally. The company focuses on advancing research, integrating programs, and manufacturing of products that target and treat diabetes, pain, and cancers, as well as address psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. It offers oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams.
Phoenix Life Sciences International Limited Fundamentals Summary
PLSI fundamental statistics | |
---|---|
Market cap | US$1.40k |
Earnings (TTM) | -US$3.12m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs PLSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PLSI income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$3.12m |
Earnings | -US$3.12m |
Last Reported Earnings
Feb 28, 2019
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did PLSI perform over the long term?
See historical performance and comparison